How nicotine pouches affect users and public health
Official title: THRIVE Study: Informing Oral Nicotine Pouch Regulations to Promote Public Health
Run by Ohio State University Comprehensive Cancer Center · NCT07503925 · Data updated 2026-11-12
This study tests different nicotine pouch types and concentrations to see how they feel to users and whether people switch from cigarettes to pouches.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | June 26, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 17, 2026 |
| Trial ID | NCT07503925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21 or older who exclusively use nicotine pouches, have used them daily for at least three months, and meet language, vision, and device requirements.
✕Probably not a fit
Individuals who do not currently use nicotine pouches or who do not meet the switching criteria may not benefit from the study outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults who currently use nicotine pouches to compare how nicotine concentration, form, and isomer affect satisfaction, appeal, and potential switching from cigarettes. Participants complete three clinic visits and two week-long switching periods with daily diary surveys, using study-provided nicotine pouches. The study examines whether high nicotine content and certain particle characteristics increase user liking and influence switching from cigarettes to nicotine pouches. Results will help interpret prior aims and inform regulation and product design for commercially available nicotine pouches.
Why it matters
Potential benefit: If successful, findings could inform safer product design and support strategies that help smokers switch to nicotine pouches.
How similar studies have gone: Prior research on nicotine pouches suggests product features can affect satisfaction and switching, but this study adds prospective, controlled switching data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 21 or older * Able to read and speak English * Willing to abstain from tobacco, nicotine, and marijuana for at least 12 hours prior to study visits * Exclusive use of ONPs (other product use \<10x/mo). * Exhaled CO reading \<10 ppm * Owns a smartphone and can receive SMS text messages with embedded survey links * Negative pregnancy test at V1 and V2 (if applicable) * Uses ≥1.5 cans of ONPs/week * Daily use of ONPs for the past 3 months * At least half of ONPs used are 6mg nicotine concentration. Exclusion Criteria: * Non-English speaker * Individuals currently pregnant, planning to become pregnant, or breastfeeding are excluded due to potential risks associated with nicotine exposure and study procedures (e.g., blood draws). * Individuals with unstable or significant psychiatric conditions are excluded to minimize risk and ensure reliable participation. * Individuals actively attempting to quit nicotine use are excluded to avoid ethical concerns and ensure that study participation does not interfere with cessation efforts * Non-nicotine users and regular tobacco users are excluded from the clinical trial component to ensure that participants have established use patterns appropriate for assessing ONP use behaviors.
Where it's running
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Brittney L. Keller-Hamilton, PhD, MPH — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State University Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 800-293-5066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparative evaluation of nicotine analogs for nicotine EC users
This early-stage trial tests whether two nicotine-like compounds (6-MN and nicotinamide) differ from nicotine in how they feel, how much people use them, and how they affect the body in adult e-cigarette users.
-
Graduate students' views and social influences about oral nicotine pouches
We will test whether social-norms and visual risk messages help Ohio State graduate students better understand and share accurate information about the addictive risks of oral nicotine pouches.
-
Smokefree Family Living to help Chinese American households quit smoking and reduce third‑hand smoke
This trial tests whether a tailored Smokefree Family Living program helps Chinese American smokers and their household members quit smoking and lower third‑hand smoke contamination in their homes.
-
Digital tool to help young adults quit vaping with ACT on Vaping app
A smartphone app using Acceptance and Commitment Therapy is tested to see if it helps 18-30 year-olds quit vaping, compared to a version with enhanced text support.
-
Smoke-free home program for tribal communities
This study tests whether a program that helps tribal communities create smoke-free homes can reduce secondhand smoke exposure and improve health.
-
Manipulating nicotine in e-cigarettes to improve public health
This study tests how different amounts and types of nicotine in e-cigarettes can affect addiction and health risks to help find safer options for smokers and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.